Thomas A. Raffin - Net Worth and Insider Trading
Thomas A. Raffin Net Worth
The estimated net worth of Thomas A. Raffin is at least $68 Million dollars as of 2024-04-24. Thomas A. Raffin is the Director of Akoya Biosciences Inc and owns about 17,909,839 shares of Akoya Biosciences Inc (AKYA) stock worth over $68 Million. Thomas A. Raffin is also the Director of Lumos Pharma Inc and owns about 6,962 shares of Lumos Pharma Inc (LUMO) stock worth over $20,190. Details can be seen in Thomas A. Raffin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas A. Raffin has not made any transactions after 2023-06-12 and currently still holds the listed stock(s).
Transaction Summary of Thomas A. Raffin
Thomas A. Raffin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas A. Raffin owns 3 companies in total, including Lumos Pharma Inc (LUMO) , LDR Holding Corp (LDRH) , and Akoya Biosciences Inc (AKYA) .
Click here to see the complete history of Thomas A. Raffin’s form 4 insider trades.
Insider Ownership Summary of Thomas A. Raffin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LUMO | Lumos Pharma Inc | 2015-04-07 | director |
| LDRH | LDR Holding Corp | 2015-02-19 | 10 percent owner |
| AKYA | Akoya Biosciences Inc | 2023-06-12 | director & 10 percent owner |
Thomas A. Raffin Latest Holdings Summary
Thomas A. Raffin currently owns a total of 2 stocks. Among these stocks, Thomas A. Raffin owns 17,909,839 shares of Akoya Biosciences Inc (AKYA) as of June 12, 2023, with a value of $68 Million and a weighting of 99.97%. Thomas A. Raffin also owns 6,962 shares of Lumos Pharma Inc (LUMO) as of April 7, 2015, with a value of $20,190 and a weighting of 0.03%.
Latest Holdings of Thomas A. Raffin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKYA | Akoya Biosciences Inc | 2023-06-12 | 17,909,839 | 3.82 | 68,326,036 |
| LUMO | Lumos Pharma Inc | 2015-04-07 | 6,962 | 2.90 | 20,190 |
Holding Weightings of Thomas A. Raffin
Thomas A. Raffin Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas A. Raffin has made a total of 1 transactions in Akoya Biosciences Inc (AKYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akoya Biosciences Inc is the acquisition of 2,020,000 shares on June 12, 2023, which cost Thomas A. Raffin around $10 Million.
According to the SEC Form 4 filings, Thomas A. Raffin has made a total of 0 transactions in Lumos Pharma Inc (LUMO) over the past 5 years. The most-recent trade in Lumos Pharma Inc is the sale of 2,299 shares on April 7, 2015, which brought Thomas A. Raffin around $1 Million.
Insider Trading History of Thomas A. Raffin
- 1
Thomas A. Raffin Trading Performance
GuruFocus tracks the stock performance after each of Thomas A. Raffin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas A. Raffin is -14.89%. GuruFocus also compares Thomas A. Raffin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas A. Raffin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas A. Raffin's insider trading performs compared to the benchmark.
Performance of Thomas A. Raffin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 36.03 | -14.89 | -21.69 | |||
| Relative Return to S&P 500(%) | 32.96 | -17.72 | -28.71 |
Thomas A. Raffin Ownership Network
Ownership Network List of Thomas A. Raffin
Ownership Network Relation of Thomas A. Raffin
Thomas A. Raffin Owned Company Details
What does Lumos Pharma Inc do?
Who are the key executives at Lumos Pharma Inc?
Thomas A. Raffin is the director of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .
Lumos Pharma Inc (LUMO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lumos Pharma Inc Insider Transactions
Thomas A. Raffin Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas A. Raffin. You might contact Thomas A. Raffin via mailing address: C/o Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Aimes Ia 50010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
